In recent years, there has been a dramatic increase in multi-drug resistance (MDR) amongst gram-negative pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting organisms. This has impacted the treatment of both hospital and community acquired infections. Therefore, accurate and reliable MIC determination is crucial for a successful antimicrobial therapy.
The routine MIC plate MICRONAUT-S Pseudomonas MIC provides an extended spectrum of standard and critical important backup antibiotics used for treatment of infections caused by multi-drug resistant non-fermenting pathogens. It enables MIC determination of antibiotics like piperacillin-tazobactam, ceftazidime-avibactam, ceftolozane-tazobactam, meropenem, tigecyclin and colistin in a single test run. MIC values are interpreted according to currently valid EUCAST breakpoints.
The MICRONAUT-S Pseudomonas MIC test plate offers a range of features and benefits relating to the phenotypic quantification of MIC values for critically important backup antibiotics used for treatment of bacterial infections caused by non-fermenting bacteria.
Please contact your local representative for availability in your country.
Not for sale in the USA. MERLIN Gesellschaft für mikrobiologische Diagnostika mbH – A Bruker Company (www.merlin-diagnostika.de)